Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1449717838
总结
CYP2C19 poor metabolizer phenotype is not associated with risk of adverse events due to citalopram or escitalopram in people with as compared to CYP2C19 normal metabolizer phenotype.